ES-009
- Generic Name
- ES-009
A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2023-11-15
- Lead Sponsor
- Elpiscience Biopharma Australia Pty. Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT06007482
- Locations
- 🇦🇺
Peninsula and South Eastern Oncology and Haematology Group, Frankston, Australia
🇦🇺St George Private Hospital, Kogarah, Australia
🇦🇺Scientia Clinical Research, Randwick, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath